Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dosing regimen for sedation with CNS 7056 (remimazolam)

Dosing regimen for sedation with CNS 7056 (remimazolam)

US Patent 9827251 · Granted Nov 28, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Short-acting benzodiazepine salts and their polymorphic forms2025
Dosing regimen for sedation with CNS 7056 (Remimazolam)2025
Dosing regimen for sedation with CNS 7056 (Remimazolam)2025
Dosing regimen for sedation with CNS 7056 (Remimazolam)2025
Dosing regimen for sedation with CNS 7056 (Remimazolam)2025
Short-acting benzodiazepine salts and their polymorphic forms2021
Dosing regimen for sedation with CNS 7056 (remimazolam)2020
Dosing regimen for sedation with CNS 7056 (remimazolam)2020
Dosing regimen for sedation with CNS 7056 (remimazolam)2020
Dosing regimen for sedation with CNS 7056 (remimazolam)2020
Short-acting benzodiazepine salts and their polymorphic forms2019
Dosing regimen for sedation with CNS 7056 (Remimazolam)2019